Mingfeng Hao
Impact in
-
- Cancer-related Molecular Pathways
-
- Hippo pathway signaling and YAP/TAZ
Papers in
-
- Ubiquitin and proteasome pathways 2
- Protein Degradation and Inhibitors 2
- DNA Repair Mechanisms 1
- Oncology 4
- Cancer-related Molecular Pathways 2
- PARP inhibition in cancer therapy 1
- Co-authors
- Tinghu Zhang (3 shared papers)Nathanael S. Gray (4 shared papers)Jarrod A. Marto (2 shared papers)Scott B. Ficarro (2 shared papers)Nicholas Kwiatkowski (3 shared papers)Arno L. Greenleaf (1 shared paper)Nancy M. Hannett (1 shared paper)Matthias Geyer (1 shared paper)
- Journals
- Nature Communications (1 paper)Synlett (1 paper)Journal of Medicinal Chemistry (1 paper)Polymer Engineering and Science (1 paper)Nature Chemical Biology (1 paper)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Mingfeng Hao
10 papers receiving 531 citations
Peers
Comparison fields: 5 of 73
- Oncology 148
- Cell Biology 89
- Signal Processing 47
- Molecular Biology 270
- Biomaterials 43
Countries citing papers authored by Mingfeng Hao
This map shows the geographic impact of Mingfeng Hao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingfeng Hao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingfeng Hao more than expected).
Fields of papers citing papers by Mingfeng Hao
This network shows the impact of papers produced by Mingfeng Hao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingfeng Hao. The network helps show where Mingfeng Hao may publish in the future.
Co-authors
The 25 scholars most cited alongside Mingfeng Hao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 251 | |
| 2 | 2018 | 105 | |
| 3 | 2010 | 49 | |
| 4 | 2020 | 36 | |
| 5 | 2020 | 35 | |
| 6 | 2010 | 28 | |
| 7 | 2021 | 13 | |
| 8 | 2023 | 10 | |
| 9 | 2020 | 4 | |
| 10 | 2023 | 4 |
About Mingfeng Hao
Mingfeng Hao is a scholar working on Molecular Biology, Oncology, Signal Processing, Electrical and Electronic Engineering and Cell Biology, having authored 10 papers that have together received 535 indexed citations. Recurring topics across this work include Indoor and Outdoor Localization Technologies (3 papers), Speech and Audio Processing (3 papers), Ubiquitin and proteasome pathways (2 papers), Protein Degradation and Inhibitors (2 papers), Music and Audio Processing (2 papers), Cancer-related Molecular Pathways (2 papers), PARP inhibition in cancer therapy (1 paper) and DNA Repair Mechanisms (1 paper). The work is most often cited by research in Oncology (148 citations), Cell Biology (89 citations), Signal Processing (47 citations), Molecular Biology (270 citations) and Biomaterials (43 citations). Mingfeng Hao has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Tinghu Zhang, Nathanael S. Gray, Jarrod A. Marto, Scott B. Ficarro, Nicholas Kwiatkowski, Arno L. Greenleaf, Nancy M. Hannett, Matthias Geyer, Jonathan M. Elkins and Richard A. Young. Their work appears in journals such as Nature Communications, Synlett, Journal of Medicinal Chemistry, Polymer Engineering and Science and Nature Chemical Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.